Boehringer, Gilead Freeze Antiretroviral Prices for Some U.S. Agencies [USA]

Author: Kaiser Daily HIV/AIDS Report [USA], Published on: 5 June 2008

Pharmaceutical companies Boehringer Ingelheim and Gilead Sciences are freezing the prices of their antiretroviral drugs for select agencies in the U.S..."We urge the other drug companies to follow [Boehringer's] and Gilead's lead and to freeze price increases…that keep lifesaving drugs out of reach for those who need them," [AIDS Healthcare Foundation] President Michael Weinstein said…Reponses from Abbott Laboratories, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Pfizer, Roche and Johnson & Johnson subsidiary Tibotec Therapeutics "reiterated the companies' commitment to increasing access but made no specific pledge with regard to" price freezes…

Read the full post here

Related companies: Abbott Laboratories Boehringer Ingelheim Bristol-Myers Squibb Gilead Sciences GlaxoSmithKline Johnson & Johnson Merck Pfizer Roche Tibotec (part of Johnson & Johnson)